Drug Utilization Review of Alprazolam at Thanyarak Chiangmai Hospital


  • Renu Uttiyung Thanyarak Chiangmai Hospitol


Drug Utilization Review, Alprazolam


Objective: To review drug utilization of Alprazolam at Thanyarak Chiangmai Hospital.

                Method: A retrospective study from October 1, 2016 to December 31, 2018, descriptive the nature of the prescribing and evaluation of drug prescribing of alprazolam in outpatients. In terms of indication, dose, duration, a doctor who prescribes, contraindications, precautions and adverse drug reactions.

                Result:  There were 44 cases (Forty males and four females; 685 visits), who were prescribed alprazolam. The alprazolam utilizing which accommodates the criteria for Rational Drug Use (RDU) according to the National list of essential medicines: Central Nervous System Volume 1 and Thai National Formulary 2015 Drugs used in Psychiatry were : indication (0.15%), dosage (0.15%), contraindication (9.78%), precaution ( 99.56%), adverse drug reaction (99.71%). There did not fit in the criteria : indication ( opioid dependence 70.66%, followed by insomnia 18.54%), dosage (99.85%), contraindication 90.22% (used combination with methadone 88.03%, followed by benzodiazepine 21.76%), precaution 0.44% (used 3 times in patients older than 65 years old), adverse drug reactions 0.29% ( drowsiness and confusion) and duration (100%).

                Conclusion and recommendations: Regard to the criteria for Rational Drug Use (RDU) in Psychiatry regard to the Central Nervous System Volume 1 and Thai Nation Formulary 2015, the evaluation of alprazolam prescribing found highly not fit criteria : the most was duration, followed by indication, dosage and contraindication respectively. Adverse drug reaction and precaution were 2 aspects that fit the criteria. Therefore, the hospital should have a clear policy on prescribing medication in order to make more reasonable use of medication.


Download data is not yet available.


กองควบคุมวัตถุเสพติด สำนักงานคณะกรรมการอาหารและยา. พระราชบัญญัติวัตถุออกฤทธิ์ต่อจิตและประสาท พ.ศ. 2559. กรุงเทพฯ : โรงพิมพ์สำนักงานพระพุทธศาสนาแห่งชาติ; 2560

ประกาศกระทรวงสาธารณสุขเรื่องเปลี่ยนแปลงประเภทวัตถุออกฤทธิ์ (ฉบับที่2) พ.ศ. 2555 ราชกิจจานุเบกษา เล่มที่ 129 ตอนพิเศษ 191 วันที่ 19 ธันวาคม 2555.

Sub-committee on essential drug list development. Thai national formulary 2010 central nervous system volume 1. Bangkok: Printing of agricultural co-operative federation of Thailand; 2010.

Narcotics Control Division. Important drug notes [Online]. 2019 [cited 2019 Feb 3];[1screen]. Available from: URL:http://narcotic.fda.moph.go.th/welcome/?p=674

เกณฑ์คู่มือการใช้ยาอย่างสมเหตุผลตามบัญชียาหลักแห่งชาติยาที่ใช้ทางจิตเวช Thai National Formulary 2015 Drugs used in Psychiatry. [Online]. 2019 [cited 2019 Jan 30]; [1 screen]. Available from: URL: http://ndi.fda.moph.go.th/uploads/main_drug_file/20171115141805.pdf

Pek EA, Remfry A, Pendrith C, Fan-Lun C, Bhatia RS, Soong C. High prevalence of inappropriate benzodiazepine and sedative hypnotic prescriptions among hospitalized older adults. J Hosp Med 2017; 12:310-6.

Zandstra SM, Furer JW, van de Lisdonk EH, Bor JH, Zitman FG, van Weel C. Differences in health status between long-term and short-term benzodiazepine users. Br J Gen Pract 2002 Oct;52(483):805-8.

Assanangkornchai S, Chittrakam S, Thaikla K, Tantirangsee N. Prescription drug abuse : introduction and situation in Thailand. Bangkok : Office of the Narcotics Control Board ; 2012

Aumpon V. Study of measures resolving the abuse of psychotropic substances consumption on benzodiazepines group. FDA Journal 2013 ; 20 : 21-9.

World Health Organization. Clinical guidelines for withdrawal management and treatment of drug dependence in closed settings. Ann Oncol. 2009; 40-43.






Original Article